Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**CLIC1pep** is a peptide targeting Chloride Intracellular Channel Protein 1 (**CLIC1**), a protein involved in ion channel function and implicated in cancer cell migration, invasion, and metastasis. CLIC1, typically cytoplasmic, translocates to the plasma membrane under oxidative stress to form chloride ion channels that regulate cell volume and motility in tumor microenvironments. CLIC1pep likely functions as a selective inhibitor peptide, designed to bind CLIC1 and block its channel activity or membrane insertion, thereby suppressing cancer progression. Developed as a research tool or potential therapeutic, it exemplifies peptide-based modulation of intracellular channels for oncology applications, leveraging high specificity and minimal off-target effects characteristic of targeted peptides.[1][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CLIC1pep.